1. Home
  2. TCMD vs FTH Comparison

TCMD vs FTH Comparison

Compare TCMD & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tactile Systems Technology Inc.

TCMD

Tactile Systems Technology Inc.

N/A

Current Price

$25.63

Market Cap

541.6M

Sector

Health Care

ML Signal

N/A

Logo Faeth Therapeutics Inc. Common Stock

FTH

Faeth Therapeutics Inc. Common Stock

N/A

Current Price

$7.94

Market Cap

507.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TCMD
FTH
Founded
1995
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
541.6M
507.8M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
TCMD
FTH
Price
$25.63
$7.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
15
Target Price
$36.33
★ $56.15
AVG Volume (30 Days)
186.9K
★ 679.1K
Earning Date
11-02-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 17.14
N/A
EPS
★ 0.57
N/A
Revenue
N/A
N/A
Revenue This Year
$9.95
N/A
Revenue Next Year
$9.49
N/A
P/E Ratio
$45.61
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.53
$8.54
52 Week High
$37.77
$42.14

Technical Indicators

Market Signals
Indicator
TCMD
FTH
Relative Strength Index (RSI) 53.31 23.28
Support Level $23.14 N/A
Resistance Level $27.06 $21.97
Average True Range (ATR) 1.33 1.77
MACD -0.10 -0.45
Stochastic Oscillator 59.65 0.40

Price Performance

Historical Comparison
TCMD
FTH

About TCMD Tactile Systems Technology Inc.

Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system, provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.

About FTH Faeth Therapeutics Inc. Common Stock

Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.

Share on Social Networks: